Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2014-07-10
DOI
10.1155/2014/424239
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
- (2013) Joao Tomé-Carneiro et al. CURRENT PHARMACEUTICAL DESIGN
- Dose-Dependent Interaction of trans-Resveratrol with Biomembranes: Effects on Antioxidant Property
- (2013) Stalin Selvaraj et al. JOURNAL OF MEDICINAL CHEMISTRY
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling
- (2012) Sheng-jun Wang et al. BRAIN RESEARCH
- Inhibition of Na+-H+ exchange as a mechanism of rapid cardioprotection by resveratrol
- (2012) Luong Cong Thuc et al. BRITISH JOURNAL OF PHARMACOLOGY
- Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
- (2012) Felix Keil et al. EUROPEAN JOURNAL OF CANCER
- Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity
- (2012) Jaroslaw Dudka et al. Evidence-based Complementary and Alternative Medicine
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Cardiovascular effects and molecular targets of resveratrol
- (2012) Huige Li et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Liposomal drug formulations in cancer therapy: 15 years along the road
- (2011) Marije Slingerland et al. DRUG DISCOVERY TODAY
- The effect of resveratrol on the prevention of cisplatin ototoxicity
- (2011) T. Erdem et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Enhancement of Cancer Chemosensitization Potential of Cisplatin by Tea Polyphenols Poly(lactide-co-glycolide) Nanoparticles
- (2011) Madhulika Singh et al. Journal of Biomedical Nanotechnology
- Role of Akt-Dependent Pathway in Resveratrol-Mediated Cardioprotection after Trauma-Hemorrhage
- (2011) Yung-Fong Tsai et al. JOURNAL OF SURGICAL RESEARCH
- Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
- (2011) Jochen H Lorch et al. LANCET ONCOLOGY
- Resveratrol in human cancer chemoprevention - Choosing the ‘right’ dose
- (2011) Edwina Scott et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model
- (2011) Man-Yi Wong et al. Nanomedicine-Nanotechnology Biology and Medicine
- 5-Fluorouracil Increases the Chemopreventive Potentials of Resveratrol Through DNA Damage and MAPK Signaling Pathway in Human Colorectal Cancer Cells
- (2011) Purusottam Mohapatra et al. ONCOLOGY RESEARCH
- Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
- (2010) Kazuo Maruyama ADVANCED DRUG DELIVERY REVIEWS
- Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study
- (2010) M. Merlano et al. ANNALS OF ONCOLOGY
- Liposomal cisplatin: a new cisplatin formulation
- (2010) George P. Stathopoulos ANTI-CANCER DRUGS
- Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: The roles of caspase-6 and p53
- (2010) Jason Yongsheng Chan et al. CANCER BIOLOGY & THERAPY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects
- (2010) J. Brittes et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Long-Term Outcome and Morbidity After Treatment With Accelerated Radiotherapy and Weekly Cisplatin for Locally Advanced Head-and-Neck Cancer: Results of a Multidisciplinary Late Morbidity Clinic
- (2010) Heidi Rütten et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes
- (2009) Olga Wesołowska et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
- (2009) Teni Boulikas EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Application of Simplex Lattice Design and Desirability Function for the Formulation Development of Mouth Dissolving Film of Salbutamol Sulphate
- (2009) Mukesh Gohel et al. Current Drug Delivery
- Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes
- (2008) Sabrina Fabris et al. BIOPHYSICAL CHEMISTRY
- Drug binding and mobility relating to the thermal fluctuation in fluid lipid membranes
- (2008) Emiko Okamura et al. JOURNAL OF CHEMICAL PHYSICS
- Differential Scanning Calorimetry (DSC): A Tool to Study the Thermal Behavior of Lipid Bilayers and Liposomal Stability
- (2008) Costas Demetzos JOURNAL OF LIPOSOME RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started